Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study

  • 1,
  • 2Email author and
  • 3
BMC International Health and Human Rights201818:27

https://doi.org/10.1186/s12914-018-0168-0

  • Received: 16 September 2017
  • Accepted: 20 June 2018
  • Published:
Open Peer Review reports

Abstract

Background

Maternal and neonatal tetanus (MNT) is still the major public health problem in about 25 countries, mainly in Africa and Asia. However, the utilization of intervention strategies, like tetanus toxoid (TT) immunization remains low in these countries. In Ethiopia, only 49% of the pregnant mothers received TT2+ in 2016. This study was designed to evaluate perceptions and factors affecting the utilization of TT immunization among reproductive-age women in Dukem town, Eastern Ethiopia, 2016.

Methods

We conducted a community-based cross-sectional study from May to October 2016. A simple random sampling method was employed to select samples of 422 women. Data were collected using a, pretested semi-structured and a face-to-face interviewer-administered questionnaire. We entered data in to Epi Info version 7 and analyzed them by SPSS version 20 software. Odds ratios and a 95% CI at 0 < 0.05 p-value were calculated to ascertain the significance of associations.

Results

Response rate was 98.6% (N = 416). Mean age with standard deviation was 29.25± 5.11 years, and average family size was 4.19. Our study showed the utilization of TT immunization was 39.2% (N = 163). Of the participants, 33.9% (N = 141) had never been vaccinated. ANC follow up service [AOR: 2.56, 95% CI: (1.18, 5.49)], distance from health facilities [AOR: 2.27, 95% CI: (1.27, 4.09)], knowing vaccination date [AOR: 1.98, 95% CI: (1.23, 3.18)], having a TV set in the house [AOR: 1.80, 95% CI: (1.11, 2.917)], maternal education [AOR: 1.41, 95% CI: (1.84, 2.30), and place of delivery [AOR: 1.19, 95% CI: (1.00, 1.43)] were factors significantly associated with the utilization of TT immunization.

Conclusions

This study indicated the utilization of TT immunization was low. ANC service follow up, distance from health facilities, knowing vaccination date, having a TV in the house, mothers’ educational status, and place of delivery were significant predictors. Our study suggests that policymakers and other stakeholders should consider the need for increasing access to maternal education, like basic adult education, ANC follow up services, providing accessible health facilities, improving varieties of communication media, promoting female occupational status, and providing appropriate vaccination cards.

Keywords

  • Tetanus Toxoid Immunization
  • Reproductive- age women
  • Cross-sectional
  • Determinants
  • Ethiopia

Background

Maternal and neonatal tetanus (MNT) is still the major public health problem, in about 25 countries, mainly in Africa and Asia [13]. Maternal and neonatal tetanus is a condition which occurs under poor hygienic practices during delivery performances [4]. Tetanus which occurs during pregnancy or within 6 weeks of the end of pregnancy is called maternal tetanus (MT) and neonatal tetanus (NT) is tetanus that occurs in the first 28 days of life [5]. NT is an acute disease caused by a tetanus toxin produced by bacteria called Clostridium Tetani. The spores enter the body through an unhealed umbilical cord [6].

Despite the initiatives of the World Health Organization (WHO) for tetanus elimination, it still continues to cause a significant maternal and neonatal mortality. Annually, it claims about 180,000 lives worldwide [4]. In the poorest parts of the world, neonatal tetanus (NT) is responsible for 14% of the neonatal deaths, while maternal tetanus (MT) is responsible at least for 5% of maternal deaths [7]. An estimated 15,000–30, 000 women have been dying every year from tetanus contracted during or shortly after pregnancy [8].The risk for tetanus in women and neonates is especially high in developing countries. This is because in such countries,women are not well protected through full tetanus immunization; persistent unsafe delivery practices or limited accessibility prevail; and unhygienic cord care practices continue [9].In 1999, WHO estimated that about 17,875 neonatal tetanus cases and 13,406 NT deaths took place in Ethiopia making the country a contributor of 4.6% of the global NT deaths [10].

Both maternal and neonatal tetanus are preventable health problems. Proper implementations of maternal immunization programs, like the TT immunization is one of the basic intervention strategies used to alleviate these situations. Tetanus toxoid immunizations are injections given during pregnancy for the prevention of NT. A pregnant woman should receive at least two doses of TT injections during each pregnancy to realize full tetanus protection. Five doses are considered to provide lifetime protection irrespective of the recommended intervals [11]. Studies proved that immunization of pregnant women or women of childbearing age with at least two doses of TT could have the potential to decrease mortality from NT [6, 12]. Moreover, clean delivery practices and appropriate tetanus surveillance are the other basic approaches for MNT prevention [5, 9, 12].

In many parts of low-income countries, however, despite the efforts made to improve maternal and neonatal protection through TT immunization programs, valid doses of TT (two and more) immunization coverage still remains low [3]. For instance, about 27% of the participant women did not receive any TT vaccination during their most recent pregnancies in India [13]. A report from Pakistan demonstrated that only 55.6% of the participants received the complete TT vaccination [14].

Similarly, the majority of the Sub-Saharan African countries could hardly reach the TT immunization target set to be covered. Because of this, they have not yet fully achieved the complete elimination of MNT. Accordingly, a study from Nigeria showed that only 40.8% of TT2 coverage was achieved while 44.4% of mothers did not receive any TT vaccination [15]. Ethiopia is one of the countries which have not fully achieved the complete elimination of MNT [5, 16] due to the low TT coverage achieved. According to Ethiopian Demographic and Health Survey (EDHS) reports of 2016, only 49% of women received sufficient doses of TT (TT2+) [17]. It could be concluded that most African countries could not reach the WHO Global Immunization target of at least 90% national vaccination coverage and at least 80% vaccination coverage in every district [18].

Evidences show that a range of determinant factors affect the utilization of TT immunization. For instance, women’s education and their wealth index can impose variations in immunization coverage [17, 19, 20]. Mothers’ immunization status also differs from urban to rural as well as from one part of the country to the other [21, 22]. Furthermore, studies indicate that maternal age, marital and occupational status, distance from health facilities, number of visits to healthcare facilities, and the number of children in the house can also considerably determine TT immunization usage [2224].

Surprisingly, we lack evidences demonstrating the number of factors influencing the utilization of TT immunization and mothers’ perceptions of the immunization in Dukem town, East Showa Zone, Ethiopia. Thus, this study intended to investigate the level and ranges of factors affecting the utilization of TT immunization among reproductive age women in Dukem town, Eastern Ethiopia. The finding would probably help us to generate supplementary evidences that strengthen and accelerate current efforts to eliminate MNT.

Methods

Aims

This study was intended to investigate the status and factors determining the utilization of TT immunization among reproductive age women in Dukem town, Eastern Ethiopia.

Study design, setting, and period

A cross-sectional study design was employed to assess the level and factors affecting the utilization of TT immunization. We collected data based on the number of reproductive -age women currently living in Dukem town from May to October 2016.

Study area

Dukem town, which is located 35 km to the East of Addis Ababa, the capital of Ethiopia, was our study area. We purposively selected the town and its surroundings. In its four kebeles, the town had a projected total population of 114, 207 according to the 2007 population and housing census of the Central Statistical Agency (CSA) of Ethiopia [25]. Child bearing age women (CBAW) were estimated to be 25,234 (22.2%) of the total population, and approximately 3957(3.47%) of them became pregnant annually. The health facilities of the town during the study included a public health center, a maternal and child health (MCH) clinic, four public health posts and eight medium private clinics.

Source population

The source population was all child bearing age women who were living in Dukem town at the moment.

Inclusion and exclusion criteria

Inclusion criteria

All women in the reproductive age group who had lived in the study area for at least two years were included.

Exclusion criteria

We excluded all reproductive age women who had never given births in the past 2 years.

Sample size and Sampling procedures

We employed the simple random sampling method to select eligible participants. Participant mothers were proportionally selected based on the number of resident mothers in each of the 4 kebeles. Single population proportion was used to calculate the required sample size. A 50% assumption of prevalence and an absolute precision of 5% were considered. We also assumed of a 95% confidence level to obtain adequate power for analysis. After including an additional grant of 10% for no response, 422 women were included.

Operational definitions

♣ Child Bearing Age Women (CBAW) - Any women aged 15 to 49 years irrespective of fertility status.

♣ Vaccinated by history: Mothers’ self-report of TT vaccination doses received without any documented evidences.

♣ Vaccinated by card only: A documented evidence of TT doses on immunization cards only.

♣ Vaccinated by card plus history: Both documented and mothers’ self-reported TT doses received.

♣ Valid TT doses: Mothers who received at least 2 doses of TT (TT2) in the recommended intervals

Data collection tools and techniques

We collected data by using a semi-structured interviewer administered questionnaire. The questionnaire was adopted from the Ethiopian demographic and health survey and other related literature [10, 19, 20, 2426]. We employed a face-to-face interviewer administered data collection technique. We included age, mothers’ marital status, mother and husband’s educations, mothers’ ethnic group, religion, radio and TV in the house to gather information on the socio-demographic characteristics of the participants. There also were questions about mothers’ future birth intentions, ANC service follow ups, parity of birth, permission from husbands to go to health facilities, and knowing the next date of TT vaccination dose to evaluate the determinants of TT vaccination among participants.

Questions like the accessibility of vaccination site, quality of services provided, behavior of health care providers, time for travel to health facilities, privacy issues during services, and husbands’ encouragement to visit HF were also incorporated to assess mothers’ perceptions toward the utilization of TT vaccinations. We also asked some questions concerning mother’s knowledge of the purpose of TT immunizations.

Data quality control

We emphasized quality in the data collection tools. The questionnaire was first designed in English and translated into the local language ‘Afaan Oromoo’ and back to English by language experts to verify its consistency. We also recruited 7 data collectors and 5 supervisors (health extension workers) who had experience and skills in the task. They were trained and oriented for 2 days before the actual survey. The training focused on the purposes of the study, clarity of tools, techniques of interview, confidentiality of information, informed consent, and the roles & responsibilities of data collectors and supervisors. During the data collection process, the principal investigator supervised both groups. Moreover, we conducted a pretest study prior to the actual process to test the validity and consistency of the data collection instrument by using 10% of the sample in a neighboring town, Gelan. Based on the pretest analysis, we modified some misinterpretations, minimized the number of interview questions, and made corrections to some other objections.

Data management and analysis

The collected data were checked manually for clarity and completeness. We coded data, labeled, verified, categorized, and entered into EpiInfo version 7. We employed SPSS version 20 to analyze the data. Descriptive statistics, like frequencies, percentages, means and standard deviations were computed. Using a binary logistic regression analysis, we fitted each predictor variable in to a bivariate logistic regression model separately to explore associations with the dependent variable (TT immunization status). Significant predictors at p-value < 0.2 in a bivariate analysis were exported to the multivariable logistic regression model to control possible effects of confounders. Variables were dropped in to the multivariate logistic regression model with a backward variable selection method. We proved goodness of fit model by Hosmer and Lemeshow and the assumption was satisfied (p-value > 0.05). Odds ratios (OR) with 95% confidence intervals (CI) were applied to ascertain the significance of association.

Results

Socio-economic characteristics

Out of the total 422 sampled mothers, 416 (98.6%) fully responded to the interview questionnaire and included in the analysis. The mean age was 29.25 years and the standard deviation + 5.11. The majority, 414 (99.5%), of the respondents were in the age group of 19–43 years. Average family size was 4.19. Seventy-eight (18.8%) of the respondents never attended any formal school. The majority of the participants, 295 (70.9%) belonged to the Oromo ethnic group (Table 1).
Table 1

Socio-demographic characteristics of the participants in Dukem town, Ethiopia, 2016

Variables (N = 416)

Frequency

Percentage (%)

Religion

 Orthodox

263

63.2

 Catholic

20

4.8

 Protestant

105

25.2

 Muslim

28

6.7

Maternal education

 Never attended

78

18.8

 Only read & write

92

22.1

 primary school

112

26.9

 Secondary and above

134

32.2

Husband education

 Never attended

60

14.4

 Only read & write

68

16.3

 Primary school

95

22.8

 Secondary and above

193

46.4

Maternal ethnic group

 Oromo

295

70.9

 Amhara

90

21.6

 Guraghe

22

5.2

 Tigrie

9

2.3

Mothers marital status

 Married

328

78.8

 Divorced

49

11.8

 Widowed

15

3.7

 Never married

12

2.9

 Separated

12

2.8

Monthly income

 ≤500ETB

28

6.7

 501-1000ETB

93

22.3

 > 1000ETB

295

71.0

Radio in the house

 Yes

249

59.9

 No

167

40.1

TV in the house

 Yes

261

62.7

 No

155

37.3

Keys:-EBT Ethiopian Birr; N number; TV Television

Determinants of TT immunization utilization

Two hundred fifty one (60.3%) of the participants gave birth to 2–4 children in their life. The majority, 218 (52.4%), of the mothers did not have future intention of giving birth. Two hundred seventy-five (66.1%) mothers visited health institutions less than 4 times for ANC services in their last pregnancy. Of the participants, 243 (58.4%), reported that the evidence of TT immunization they utilized was history (Table 2).
Table 2

Determinants of the utilization of TT immunization, Dukem town, Ethiopia, 2016

Variables (N = 416)

Numbers

Percentages (%)

Parity of Birth

 1

142

34.2

 2–4

251

60.3

 ≥ 5

23

5.5

Future intention of birth

  

 wants

142

34.1

 Don’t want

218

52.4

 Not decided

56

13.5

Permission of husband to go to HF

 No restrictions

204

49.0

 Restricted some times

143

34.4

 Restricted at all

69

16.6

Follow up of ANC services

 Yes

363

87.2

 No

53

12.8

Number of ANC services Visited

 Once

71

17.1

 twice

92

22.1

 three times

112

26.9

 Four or more times

141

33.9

TT vaccination evidences

 By history

243

58.4

 By card

173

41.6

Vaccination status

 Not vaccinated

141

33.9

 TT1

112

26.9

 TT2+

163

39.2

Knowing the next TT vaccination dates

 Yes

293

70.4

 No

123

29.6

Place of deliver

 Health institution

276

66.8

 At home

138

33.2

Keys: -ANC Antenatal care; HF Health facilities; TT Tetanus toxoid

Valid TT doses utilization status

In this study, a significant proportion of the mothers, 33.9% (N = 141) [95% CI: (29.6, 38.2)] reported they were never vaccinated with any doses of TT drug and had no documentation (card). Out of the interviewed mothers, only 39.2% (N = 163) were vaccinated the valid (TT2+) doses, and one hundred twelve (26.9%) [95% CI: 22.8, 31.0] were vaccinated by the TT1 vaccination dose (Fig. 1).
Fig. 1
Fig. 1

Valid TT immunization utilization status in Dukem Town, Western Ethiopia, 2016

Mothers’ perceptions towards utilization of TT vaccination

We also interviewed the participants about their perceptions of TT vaccination utilization. A high proportion, 87.5% (N = 364) of the participants indicated that there were accessible vaccination sites closest to their dwellings. One hundred ninety-eight (47.6%) of the mothers ranked the services provided as “good”. More than half, 54.3% (N = 226) of the participant mothers pointed out waiting time for services at facilities was> 1 h (Fig. 2 & Table 3).
Fig. 2
Fig. 2

Mothers’ waiting time during TT services at health facilities, Dukem Town, Western Ethiopia, 2016

Table 3

Participants’ perceptions towards utilization of TT immunization, 2016 (N = 416)

Variables

Frequency

Valid Percent

Accessibility of vaccination site

 Yes

364

87.5

 No

52

12.5

Where the health workers respectful

 Yes

250

60.0

 No

158

37.9

 Don’t know

8

2.1

Lack of privacy is a problem

 Yes

84

20.2

 No

270

64.9

 Don’t know

62

14.9

Quality of service given

 Good

198

47.6

 Satisfactory

161

38.7

 Poor

48

11.5

 Don’t know

9

2.2

Behaviors of health workers

 Very Good

70

16.8

 Fair

287

69.0

 Bad

59

14.2

Cancelation of vaccine schedule

 Yes

179

42.2

 No

237

57.8

Reason of schedule cancelation

 For my health problem

25

6.0

 Lack of information

115

27.6

 Lack of drug

39

9.4

 Those who are not canceled and started

237

57.0

Complains TT drug after vaccination

 Health Effects

98

23.6

 Others effects

18

4.4

 No Effects and not vaccinated

300

72.0

Time to travel to HF

 15 min

37

8.9

 15–30 min

146

35.1

 30–60 min

161

38.7

>one hour

72

17.3

Husband encourages to visit HF

 Yes

280

67.3

 No

136

32.7

Keys: - TT Tetanus toxoid; N number; min minutes; HF health facilities

Mothers’ perceived purposes of TT immunization

Figure 3 below shows the knowledge of mothers about the purposes of TT immunizations. Of the mothers who were vaccinated valid TT doses, 40.9% (N = 67) stated the purpose of TT immunization was to prevent mothers and children from getting tetanus disease, while 34.5% (N = 56) said the purpose was to prevent children alone (Fig. 3).
Fig. 3
Fig. 3

Mothers’ perceived purposes of TT immunization, Dukem Town, Western Ethiopia, 2016

Factors affecting utilization of TT immunization

Bivariate logistic regression analysis demonstrated that explanatory variables, like maternal education, occupational status of mothers, monthly income, TV set in the house, parity of birth, ANC service follow up, knowing TT vaccination dates, distance from health facilities, and place of birth were considerably related to maternal TT immunization status.

After controlling possible sources of confounders in the multivariable logistic regression model, mothers’ educational level, TV set in the house, occupational status of mothers, ANC service follow up, knowing TT vaccination date, distance from health facilities, and place of birth indicated a significant association with the utilization of TT vaccination. Accordingly, literate mothers were 1.41 times more likely to be immunized than illiterate mothers [AOR: 1.41, 95% CI: (1.18, 2.30)]. Participants who used TV in their house showed 1.8 times higher chance for TT immunization usage [AOR: 1.80, 95% CI: (1.11, 2.92)]. The multivariable logistic regression model also showed that mothers utilizing ANC service follow ups were 2.56 times more likely to utilize TT immunization [AOR: 2.56, 95% CI: (1.18, 5.49)] than those who did not follow ANC services. Moreover, mothers who were far from health facilities by < 30 min were 2.27 times more likely to be immunized compared to those who were far by ≥ 30 min [AOR: 2.27, 95% CI: (1.27, 4.09)]. The model also explained that respondents who knew TT vaccination dates had 1.98 times higher possible utilization of TT immunization [AOR: 1.98, 95% CI: (1.23, 3.18)] compared to who did not know vaccination dates (Table 4).
Table 4

Factors affecting the utilization of TT immunization, Dukem town, Ethiopia, 2016

Variables (N = 416)

TT Immunization Status

COR (95% CI)

AOR (95% CI)

p-value

≤TT1

TT2+

n = 253

n = 163

Maternal education

 Illiterate

146(25.5%)

50(74.5%)

3.03(2.03,4.47)

1.41(1.84, 2.30)

0.003+

 Literate

107(48.6%)

113(51.4%)

1

1

 

Maternal occupation

 Employed

153(67.4%)

74(32.6%)

1.84(1.23,2.74)

1.27(1.08,1.49)

0.011+

 Non-employed

100(52.9%)

89(47.1%)

1

1

 

Monthly income

 < 1000 ETB

88(67.8%)

40(31.2%)

1.62(1.04,2.52)

1.2(0.02,1.39)

0.03a

 > 1000 ETB

165(57.5%)

122(42.5%)

1

1

 

TV in the house

 Yes

186(65.7%)

97(34.3%)

1.64(1.09,2.47)

1.80(1.11,2.92)

0.002+

 No

77(53.8%)

66(46.2%)

 

1

 

Parity of birth

 < 2

174(63.5%)

100(36.5%

1.38(1.02,2.26)

1.14(0.96,1.36)

0.03a

 > 2

79(55.6%)

63(44.4%)

1

1

 

ANC service follow up

 Yes

97(72.9%)

36(27.1)

2.2(1.40,3.43)

2.56(1.18,5.49)

0.002+

 No

156(54.6%0

127(45.4%)

1

1

 

Knowing vaccination date

 Yes

93(85.3%)

16(14.7%)

5.3(3.00,9.5)

1.98(1.23,3.18)

0.005+

 No

160(52.1%)

147(47.9%)

1

1

 

Distance from HF

 < 30 min

122(66.7%)

61(33.3%)

1.56(1.04,2.32)

2.27(1.27, 4.09)

0.001+

 ≥ 30 min

131(56.2%)

102(43.8%)

1

1

 

Place of delivery

 Health facility

180(64.3%)

100(35.7%)

1.60(1.02,2.36)

1.19(1.00,1.43)

0.004+

 Home

73(52.9%)

63(47.1%)

1

1

 

Keys: - a = significant in a bivariate analysis; + = significant in a multivariable analysis; AOR Adjusted odds ratios; CI Confidence interval; COR Crude odds ratios; ETB Ethiopian Birr; HF Health facilities; TT Tetanus toxoid; TV Television

Discussion

This study employed a community-based quantitative cross-sectional study to explore factors affecting the utilization of TT immunization and perceptions of the service among reproductive age women in Dukem town, Eastern Ethiopia. The study also aimed to quantify the level of the utilization of TT immunization in the area. We found the prevalence of valid TT dose (≥TT2+) utilization was 39.12% [95% CI: (32.8, 41.0)]. The study also revealed that only 41.1% of the participants used TT vaccination by card. In this study, a notable proportion (33.9%) of the participants were never vaccinated any dose of TT.

Our finding indicated TT immunization utilization status was relatively lower compared to the national 49% reported by the Ethiopian Demographic and Health Survey (EDHS) of 2016 [17] and a prevalence of 60.8% from other parts of the country [19]. This disparity might be due to lack of uniform performance commitment to implement TT vaccination services in all regions of the country. This is in line with other study reports in that immunization coverage varies among communities of the same territory [11].

Our finding was also lower than the TT vaccination status reported by studies in Pakistan [14] and Bangladesh [11], which was 55.6% in both countries, and prevalence of 61.4% TT utilization reported from Kenya [27] and 68% from India [28]. This could be due to differences in cultural and socio-economic factors such as the level of knowledge and information about vaccination, healthcare delivery systems, like the availability of health centers for vaccination, the prevalence of vaccine-preventable diseases, methodological differences in measuring immunization status, and the existing political environment [29].

Our finding indicated the level of maternal education, maternal occupational status, ANC service follow up, distance from health facilities, media exposure, knowing vaccination date, and places of delivery considerably predicted the utilization of TT immunization.

The result of the multivariate logistic regression model explained that mothers’ educational status was significantly associated with the utilization of TT immunization. Hence, literate mothers were significantly more likely to be immunized than illiterate mothers. This result was consistent with other study reports [11, 15, 19, 28, 3032]. The possible reason might be due to differences in knowledge between the two groups about TT vaccination services. Educated mothers are often more confident decision makers regarding their own care-seeking behaviors. Because of this, educated women are often granted more status in most social interactions. In addition, care providers treat them more respectfully since they can easily communicate with them. Other studies also stated similar explanations [20, 28, 33].

The 2016 EDHS report [17] also found a similar result. The survey showed that a large number of the women (83%) whose last live births were protected against NT were more educated (over secondary school) compared to non-educated women only 41% of whom had protected live births. Therefore, maternal education is a vital tool through which we can realize the utilization of TT immunization coverage. Ensuring access to maternal education such as the expansion of basic adult education and other forms of informal educational coverage for women should go hand in hand with a successful implementation of TT immunization.

In this study, maternal ANC service follow up markedly increased the likely hood of the utilization of TT immunization. Women who regularly attended ANC service follow ups had a higher probability of TT vaccination utilization. This was supported by other findings [14, 23, 27, 31, 34, 35]. The probable explanation might be that frequent contact with healthcare providers itself upholds and boosts awareness about the benefits of utilizing complete TT vaccination. The other possible reason might be that, in Ethiopia, TT immunization is one of the ANC service packages. On the other hand, the national EDHS report of 2016 showed that 62% of women who gave birth in the last five years preceding the survey received ANC services. It could be concluded that there were a substantial number of missed opportunities for TT immunization within the same period as only 49% immunization that was too far from the ANC service was achieved. Care providers in different health facilities in the country should fill this gap by taking a better advantage of women’s ANC attendance opportunities throughout the ANC service provision procedures. Moreover, together with the recent advent of the national health policy, which focuses on accessible health service coverage, the newly gained experiences of health care services which may result in missed opportunities for vaccination have to be managed with due care. Moreover, the information provided during the services could also help to shape women’s attitude towards subsequent health services. The existence of such missed opportunities is common in other countries too [36].

Our analysis detected distance from health facilities was an important predictor of TT immunization status. In concordance with other studies [14, 37], women whose travel required only < 30 min to reach the nearest health centers had a higher chance for the utilization of TT immunization. This could be because of costs associated with distant vaccination centers in terms of time and transportation expenses. Women are most often busy at home because they are responsible for multiple responsibilities, such as caring for children and older people as well as other house hold activities. Therefore, they often hesitate to visit vaccination centers, which are relatively far from their homes. Moreover, since TT vaccination requires repeated visits to health facilities for complete immunization, such recurrent visits might be tiring for women and their children if vaccination centers are relatively far away. Ensuring accessible health facility coverage in every part of the region could lessen such problems.

The odds of TT immunization status were more likely to increase among employed mothers compared to non-employed ones. A number of studies demonstrated that TT immunization utilization depended on mothers’ occupational status [23, 27, 38, 39]. Our finding also corroborated these reports. This might be so because employed women no doubt have more access to better information and communication about health services in general and TT immunization in particular than unemployed women. Moreover, work place itself is an ideal place to promote and engage women in different health related issues, thereby enhancing women’s utilization of health care services.

Place of delivery was another determinant factor for the utilization of TT immunization. In this study, we found that mothers who gave birth at health facilities were highly likely to use TT immunization compared to those who gave birth at home. Other studies also verified this association [24, 29, 30, 35, 38]. The possible reason might be because of the opportunity for health education and advice when women deliver at health facilities. It might also be due to opportunities to provide mothers with at least the first dose of TT just immediately after delivery procedures.

Similar to the other studies [38], our analysis confirmed that knowing vaccination dates increased the odds of TT immunization utilization. A possible suggestion could be the number of contacts between care providers and client mothers. Frequent contacts with health workers could remind about the correct immunization schedules. It is important to use notification strategies such as notification through local authorities and other community leaders for vaccination dates.

Women’s media exposure, like having TV sets in houses significantly determined the status of TT immunization. In line with other studies [20, 24, 29, 38], our finding showed that women who had TV sets in their houses were more likely to indicate the utilization of TT immunization. A possible explanation might be that TV is the major information dissemination media for health service utilization. It is advisable to use alternative communication media, like the radio, school community, posters, and various community meetings.

Although we found out reliable information that can add to existing literature, some limitations could be distinguished in this study. First, the data collected were based on events that happened within the last two years preceding the study. Therefore, the problem of recall bias and under reporting might be suspected. To decrease such limitations, we focused on the most recent births and utilized vaccination cards and other records of the health facilities. Second, since the data collection technique was a face-to-face interview, there might be a social desirability bias. However, to address this issue, we carefully focused on interview techniques when we trained data collectors and supervisors.

Conclusions

This study indicated the utilization of valid TT dose immunization was low in the area. Maternal education, media exposure, ANC follow up services, knowing vaccination date, distance from health facilities, and place of delivery were significant predictors of the utilization of TT immunization. The study suggests that policy makers and other stakeholders should consider the need to ensure access to maternal education, like basic adult education. Moreover, it is advisable to promote ANC follow up services and to provide access to health facilities, varieties of communication media coverage, and appropriate vaccination cards accessible to remind about remaining TT doses.

Abbreviations

ANC: 

Antenatal care

AOR: 

Adjusted odds ratios

CI: 

Confidence interval

COR: 

Crude odds ratios

CSA: 

Central statistical agency

EDHS: 

Ethiopian demographic and health survey

HF: 

Health facility

MCH: 

Maternal and child health

MN: 

Maternal tetanus

MNT: 

Maternal and neonatal tetanus

MPH: 

Masters of public health

MSC: 

Masters of science

NT: 

Neonatal tetanus

SPSS: 

Statistical package for social science

TT: 

Tetanus toxoid

WHO: 

World Health Organization

Declarations

Acknowledgments

The authors would like to thank the University of Gondar, College of Medicine and Health Sciences, Institute of Public Health for providing ethical clearance. We would also like to extend our appreciation to all participants and data collectors.

Funding

The University of Gondar, College of Medicine and Health Sciences covered all the required financial cost of this study but did not involve in any of the activities.

Availability of data and materials

The datasets generated and analyzed during this study are not publicly available due to personal information contained within the data but are available from the corresponding author on reasonable request.

Authors’ contributions

MDA, Initiated the research concept, wrote up of the research proposal, analyzed the data, presented the results and wrote up of the draft manuscript. THM, Involved in data analysis, interpreted results and discussions, reviewed and finalized the manuscript document and corresponding author. BAD, Involved in writing up of the research proposal, writing up the draft of the manuscript and involved manuscript reviewing. All authors read and approved the final manuscript.

Ethics approval and consent to participate

We obtained ethical clearance from the Institutional Ethical Review Board (IERB) of the University of Gondar, Institute of Public Health (Reference # E.P.D460/08). We submitted letters to the health and each kebele administrative offices of Dukem town. We also communicated ethical approval letters to the randomly selected respondents and obtained oral informed consent from each participant mothers prior to the interview. Moreover, we obtained consent from families of participants under the age of 16 years. We rigorously kept and maintained the confidentiality of the data. Only aggregate data was used for our interpretation. Any involvement in the study was based on the full consent of the mothers participating in the research.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Dukem Health Office, Oromia Regional State, Dukem, Ethiopia
(2)
Department of Environmental and Occupational Health and Safety, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia
(3)
Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

References

  1. World Health Organization. Immunization coverage. Fact sheet N°378,November 2014. Available at [https://www.salute.gov.it/imgs/C_17_pagineAree_3664_listaFile_itemName_3_file.pdf]. Accessed 11 July 2017.
  2. UNICEF. Maternal and Neonatal Tetanus Elimination Initiative. Pampers UNICEF 2010 campaign launch 2009. Available at [https://www.unicef.org/corporate_partners/files/APPROVED_MNT_Report_05.06.10.pdf]. Accessed 11 July 2017.
  3. Duclos P, Okwo-Bele JM, Gacic-Dobo M, Cherian T. Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights. 2009;9(Suppl 1):S2. https://doi.org/10.1186/1472-698x-9-s1-s2.View ArticlePubMedGoogle Scholar
  4. Owusu-Darko S, Diouf K, Nour NM. Elimination of maternal and neonatal tetanus: a 21st-century challenge. Rev Obstet Gynecol. 2012;5:e151. https://doi.org/10.3909/riog0198.PubMedPubMed CentralGoogle Scholar
  5. Khan R, Vandelaer J, Yakubu A, Raza AA, Zulu F. Maternal and neonatal tetanus elimination: from protecting women and newborns to protecting all. Int J Womens Health. 2015;7:171. https://doi.org/10.2147/IJWH.S50539.PubMedPubMed CentralGoogle Scholar
  6. Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol. 2010;39(Suppl 1):i102–109.Google Scholar
  7. World Health Organization & UNICEF. Maternal and neonatal tetanus elimination by 2005: strategies for achieving and maintaining elimination, 2002. Available at [https://www.unicef.org/health/files/MNTE_strategy_paper.pdf]. Accessed 5 July 2017.
  8. WHO, UNICEF, World Bank. State of the world’s vaccines and immunization. Geneva: World Health Organization; 2009. Available at [https://www.unicef.org/immunization/files/SOWVI_full_report_english_LR1.pdf]. Accessed 2 July 2017.
  9. Thwaites CL, Beeching NJ, Newton CR. Maternal and neonatal tetanus. Lancet. 2015;385:362–70. https://doi.org/10.1016/s0140-6736(14)60236-1.View ArticlePubMedGoogle Scholar
  10. Ethiopia National Expanded Programme on Immunization. Comprehensive Multi-Year Plan 2016–2020. Addis Ababa: Federal Ministry of Health; 2015. Available at [www.nationalplanningcycles.org/.../ethiop_cmyp_latest_revised_may_12_2015.pdf]. Accessed 11 July 2017.
  11. Mohammad M. Determinants of the utilization of the tetanus toxoid (TT) vaccination coverage in Bangladesh: evidence from a Bangladesh demographic health survey 2004. The Internet J Health. 2008;8(2).Google Scholar
  12. Khan AA, Zahidie A, Rabbani F. Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries-a systematic review. BMC Public Health. 2013;13(322).Google Scholar
  13. Singh A, Pallikadavath S, Ogollah R, Stones W. Maternal tetanus toxoid vaccination and neonatal mortality in rural north India. PLoS One. 2012;7:e48891.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Naeem M, Khan M, Abbas SH, Adil M, Khan A, Naz SM, Khan MU. Coverage and factors associated with tetanus toxoid vaccination among married women of reproductive age: a cross sectional study in Peshawar. J Ayub Med Coll Abbottabad. 2010;22:136–40.PubMedGoogle Scholar
  15. Adeiga A, Omilabu S, Audu R, Sanni F, Lakehinde G, Balogun O, Olagbaju O. Tetanus toxoid immunization coverage among mothers of below one year of age in difficult-to-reach area of Lagos Metropolis. Afr J Clin Exp Microbiol. 2005;6:233–7.Google Scholar
  16. World Health Organization. Expanded Programme on Immunization Global Progress, 2015. Available at [https://www.unicef.org/supply/files/1_Zaffran_UNICEF_Industry_Consultation__Oct2015_final.pdf]. Accessed 2 July 2017.
  17. Central Statistical Agency, Addis Ababa, Ethiopia. ETHIOPIA Demographic and Health Survey 2016, July 2016. Available at [https://dhsprogram.com/pubs/pdf/FR328/FR328.pdf]. Accessed 13 July 2017.
  18. World Health Organization. Global Vaccine Action Plan 2011–2020, 2013. Available at [https://www.unicef.org/immunization/files/GVAP.pdf]. Accessed 1 July 2017.
  19. Kidane T. Factors influencing TT immunization coverage and protection at birth coverage in Tselemti District, Ethiopia. Ethiop J Health Dev. 2004;18:153–8.Google Scholar
  20. Roosihermiatie B, Nishiyama M, Nakae K. Factors associated with TT (tetanus toxoid) immunization among pregnant women, in Saparua, Maluku, Indonesia. Southeast Asian J Trop Med Public Health. 2000;31:91–5.PubMedGoogle Scholar
  21. Tesfahun F, Worku W, Mazengiya F, Kifle M. Knowledge, perception and utilization of postnatal care of mothers in Gondar Zuria District, Ethiopia: a cross-sectional study. Matern Child Health J. 2014;18:2341–51. https://doi.org/10.1007/s10995-014-1474-3.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Abdella A. Maternal mortality trend in Ethiopia. Ethiop J Health Dev. 2010;24(1).Google Scholar
  23. Biswas SC, Darda MA, Alam MF. Factors affecting childhood immunisation in Bangladesh. Pak Dev Rev. 2001:57–70.Google Scholar
  24. Abadura SA, Lerebo WT, Kulkarni U, Mekonnen ZA. Individual and community level determinants of childhood full immunization in Ethiopia: a multilevel analysis. BMC Public Health. 2015;15:972. https://doi.org/10.1186/s12889-015-2315-z.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Central Statistical Authority. Summary and Statistical report of the 2007 population and housing census of Ethiopia, Addis Ababa 2008. Available at [http://unstats.un.org/unsd/censuskb20/Attachment489.aspx?AttachmentType=1]. Accessed 13 July 2017.
  26. Central Statistical Agency. Ethiopia Demographic and Health survey 2011, Addis Ababa, 2012. Available at [https://dhsprogram.com/pubs/pdf/FR255/FR255.pdf]. Accessed 8 July 2017.
  27. Haile ZT, Chertok IRA, Teweldeberhan AK. Determinants of utilization of sufficient tetanus toxoid immunization during pregnancy: evidence from the Kenya Demographic and Health Survey, 2008–2009. J Community Health. 2013;38:492–9. https://doi.org/10.1007/s10900-012-9638-9.View ArticlePubMedGoogle Scholar
  28. Vikram K, Vanneman R, Desai S. Linkages between maternal education and childhood immunization in India. Soc Sci Med. 2012;75:331–9. https://doi.org/10.1016/j.socscimed.2012.02.043.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Mbengue MAS, Sarr M, Faye A, Badiane O, Camara FBN, Mboup S, Dieye TN. Determinants of complete immunization among senegalese children aged 12–23 months: evidence from the demographic and health survey. BMC Public Health. 2017;17:630.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Nankabirwa V, Tylleskär T, Tumwine JK, Sommerfelt H. Maternal education is associated with vaccination status of infants less than 6 months in Eastern Uganda: a cohort study. BMC Pediatr. 2010;10:92.View ArticlePubMedPubMed CentralGoogle Scholar
  31. İnakçı Hİ, Şimsek Z, Koruk İ, Koruk ST. Coverage of Tetanus Vaccine after National Tetanus Vaccination Campain and Basic Determinants in Şanliurfa. TAF Prev Med Bull. 2009;8(6).Google Scholar
  32. Onsomu EO, Abuya BA, Okech IN, Moore D, Collins-McNeil J. Maternal Education and Immunization Status Among Children in Kenya. Matern Child Health J. 2015;19:1724–33. https://doi.org/10.1007/s10995-015-1686-1.View ArticlePubMedGoogle Scholar
  33. Mohamud AN, Feleke A, Worku W, Kifle M, Sharma HR. Immunization coverage of 12-23 months old children and associated factors in Jigjiga District, Somali National Regional State, Ethiopia. BMC Public Health. 2014;14:865. https://doi.org/10.1186/1471-2458-14-865.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Hasnain S, Sheikh N. Causes of low tetanus toxoid vaccination coverage in pregnant women in Lahore district, Pakistan. East Mediterr Health J. 2007;13:1142–52.View ArticlePubMedGoogle Scholar
  35. Etana B, Deressa W. Factors associated with complete immunization coverage in children aged 12–23 months in Ambo Woreda, Central Ethiopia. BMC Public Health. 2012;12(566).Google Scholar
  36. Kalaça S, Yalçın M, Yavuz SŞ. Missed opportunities for tetanus vaccination in pregnant women, and factors associated with seropositivity. Public Health. 2004;118:377–82.View ArticlePubMedGoogle Scholar
  37. Usman HR, Kristensen S, Rahbar MH, Vermund SH, Habib F, Chamot E. Determinants of third dose of diphtheria-tetanus-pertussis (DTP) completion among children who received DTP1 at rural immunization centres in Pakistan: a cohort study. Trop Med Int Health. 2010;15:140–7. https://doi.org/10.1111/j.1365-3156.2009.02432.x.View ArticlePubMedGoogle Scholar
  38. Xeuatvongsa A, Hachiya M, Miyano S, Mizoue T, Kitamura T. Determination of factors affecting the vaccination status of children aged 12–35 months in Lao People’s Democratic Republic. Heliyon. 2017;3:e00265.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Vassiliki P, Ioanna K, Artemis V, Eleni K, Aglaia Z, Attilakos A, Maria T, Dimitris K. Determinants of vaccination coverage and adherence to the Greek national immunization program among infants aged 2-24 months at the beginning of the economic crisis (2009-2011). BMC Public Health. 2014;14:1192.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

Advertisement